DOI: 10.1055/s-00000007

Aktuelle Urologie

References

Twardowski P, Atkinson S, Boldt-Houle D. et al.
Late dosing of luteinizing hormone-releasing hormone agonists (LHRH) and testosterone (T) levels >20 ng/dL in prostate cancer (PCa).

Journal of Clinical Oncology 2020;
38: 31-31

Download Bibliographical Data

Search in:
Access: